Every modality we offer is chosen on the basis of peer-reviewed clinical evidence. We believe in showing our sources.
A summary of the evidence supporting our core modalities.
Classified as a Level 1 (best support) evidence-based treatment for ADHD by the Association for Applied Psychophysiology and Biofeedback.
Multiple RCTs demonstrate improvement in sleep onset latency, sleep efficiency, and subjective sleep quality following neurofeedback training.
Growing body of research supports PBM for traumatic brain injury, cognitive decline, and neuroprotection via mitochondrial activation.
Meta-analyses support HRV biofeedback for anxiety, depression, PTSD, and cardiovascular resilience.
The ReCODE protocol has demonstrated reversal of cognitive decline in early Alzheimer's in multiple case series and a pilot RCT.
Over 100 peer-reviewed studies support CES for anxiety, insomnia, and depression. FDA-cleared device.